iBio Inc (IBIO) concluded trading on Wednesday at a closing price of $3.36, with 168.02 million shares of worth about $564.55 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -43.57% during that period and on March 27, 2024 the price saw a gain of about 192.17%. Currently the company’s common shares owned by public are about 3.48M shares, out of which, 3.47M shares are available for trading.
Stock saw a price change of 214.02% in past 5 days and over the past one month there was a price change of 187.18%. Year-to-date (YTD), IBIO shares are showing a performance of 145.26% which decreased to -93.09% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.02 but also hit the highest price of $49.80 during that period. The average intraday trading volume for iBio Inc shares is 106.81K. The stock is currently trading 191.86% above its 20-day simple moving average (SMA20), while that difference is up 191.83% for SMA50 and it goes to -38.41% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
iBio Inc (AMEX: IBIO) currently have 3.48M outstanding shares and institutions hold larger chunk of about 7.22% of that.
The stock has a current market capitalization of $11.69M and its 3Y-monthly beta is at -3.80. It has posted earnings per share of -$26.22 in the same period. It has Quick Ratio of 0.91 while making debt-to-equity ratio of 1.79. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for IBIO, volatility over the week remained 17.56% while standing at 8.03% over the month.
Analysts are in expectations that iBio Inc (IBIO) stock would likely to be making an EPS of $0 in the current quarter, while forecast for next quarter EPS is $0 and it is $0 for next year. For the current quarter EPS, analysts have given the company a lowest target $0 which is $0 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$2.05 in the same quarter a year ago.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JMP Securities on November 29, 2021 offering a Mkt outperform rating for the stock and assigned a target price of $1.50 to it. Coverage by Cantor Fitzgerald stated iBio Inc (IBIO) stock as an Overweight in their note to investors on January 22, 2021, suggesting a price target of $3 for the stock.
